CVR 37974382Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)TrigeFounded 29 Aug 2016
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Biotest Facility ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
19
CVR registry, Aug 2026
0 (0%) over 12 months
Gross profit
6.4M
DKK, annual report 2025
+42.6% on 2024
Result
-514.3K
DKK, annual report 2025
Equity
-22.1K
DKK, annual report 2025
HMK CONSULT ApSCVR 10062926, 100% of capital and votes, since 1 Apr 2024
Mogens Kruhøffersince 1 May 2023
Equity was negative at 31 Dec 2025: -22.1K DKK. Dandex estimate, computed 6 Nov 2026.
CVR 10062926100% of capital and votesnotified 24 May 2024since 1 Apr 2024
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 1009652950% to under 66.7% of capital and votesnotified 4 May 202329 Aug 2016 to 1 May 2023
CVR 3796495620% to under 25% of capital and votesnotified 4 May 202329 Aug 2016 to 1 May 2023
CVR 3796501420% to under 25% of capital and votesnotified 4 May 202329 Aug 2016 to 1 May 2023
CVR 38281860100% of capital and votesnotified 24 May 20241 May 2023 to 31 Mar 2024
Ultimate controller
Holds 100% of capital and votes in HMK CONSULT ApS, since 11 Dec 2000
Holding company
CVR 10062926Private limited company (ApS)
Holds 100% of capital and votes in Biotest Facility ApS, since 1 Apr 2024
This company
Biotest Facility ApS
CVR 37974382
CVR records founders at incorporation. It does not record whether they are alive or still involved.
1 May 2023 to 6 Nov 2026.
29 Aug 2016 to 6 Nov 2026.
Aug 2026, monthly: 19 employees, 15 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 6 | 5 | 4 | 4 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 7 | 8 | 7 | 7 | 7 | 8 | 8 | 8 | 6 | 6 | 5 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 5 | 5 | 7 | 6 | 6 | 6 | 6 | 5 | 7 | 8 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 7 | 8 | 8 | 8 | 7 | 10 | 10 | 12 | 12 | 12 | 13 | 14 | 15 | 17 | 17 | 17 | 19 | 20 | 21 | 21 | 20 | 18 | 19 | 19 | 20 | 19 | 19 | 18 | 19 |
| FTE | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 4 | 5 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 6 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 9 | 10 | 11 | 10 | 11 | 11 | 12 | 13 | 13 | 13 | 15 | 14 | 17 | 16 | 16 | 15 | 15 | 14 | 15 | 15 | 15 | 14 | 15 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Oct 2016 to Aug 2026.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 1,694 | 1,179 | 2,870 | 4,518 | 6,441 |
| Operating profit | -57 | -474 | +334 | +469 | -667 |
| Result for the year | -74 | -402 | +234 | +339 | -514 |
| Equity | 321 | -81 | 153 | 492 | -22 |
| Total assets | 1,392 | 781 | 1,292 | 1,749 | 5,733 |
| Employees (average) | 4 | 4 | 5 | 8 | 14 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -9% | -31.1% | 143.3% | 57.4% | 42.6% |
| EBITDA | 50 | -376 | 415 | 643 | -204 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 3% | -31.9% | 14.5% | 14.2% | -3.2% |
| Employee growth (vækst i antal ansatte) | 0% | 0% | 25% | 60% | 75% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -169note 1 | Not reportednote 2 | -159 | -159 | 6 |
| Gearing, NIBD / EBITDA | Net cashnote 1 | Not reportednote 2 | Net cash | Net cash | n.m.note 3 |
| ROIC (afkast af investeret kapital) | n.m.note 4 | Not reportednote 2 | n.m.note 4 | 223.5% | -328.1%note 5 |
| Capex (investeringer i anlægsaktiver) | 0note 6 | 0note 6 | 0note 6 | 991note 7 | 733note 6 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 453note 1 | Not reportednote 2 | -170 | 90 | 666 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 1 Jul 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 19 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 1 Jul 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 4 May 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 30 Jun 2022
Each registered value from the day it took effect, newest first.
From CVR, read 6 Nov 2026. Text such as the signing rule and purpose is shown as registered.
5 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Ny adresse: c/o Mogens Kruhøffer, Røvedvej 1, Spørring, 8380 Trige
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 38281860 BioXpedia A/S (fortsættende) og CVR-nummer: 37974382 Biotest Facility ApS (ophørende).
Kapitalejerne i CVR-nummer: 38281860 BioXpedia A/S og CVR-nummer: 37974382 Biotest Facility ApS har i enighed besluttet, at der ikke skal udarbejdes en erklæring om kreditorernes stilling i forbindelse med fusionen. Kreditorer, hvis fordringer er stiftet forud for bekendtgørelsen om fusionen, og for hvilke der ikke er stillet særskilt sikkerhed, kan anmelde deres fordringer senest 4 uger efter denne offentliggørelse.
Vedtægter ændret: 01.05.2023
Bestyrelse:
Fratrådte:
Carsten Leander Buus, den 01.05.2023, Nicolai Enevold Hansen, (formand), den 01.05.2023, Agnete Lystlund Vestergaard, den 01.05.2023.
Tiltrådte:
Mogens Kruhøffer, (formand), den 01.05.2023.
Direktion:
Fratrådte:
Carsten Leander Buus, den 01.05.2023.
Tiltrådte:
Mogens Kruhøffer, (adm. dir), den 01.05.2023.
Selskabet tegnes af den administrerende direktør
Revision:
Fratrådte:
BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, den 01.05.2023.
Tiltrådte:
CVR-NR. 32895468 BEIERHOLM, STATSAUTORISERET REVISIONSPARTNERSELSKAB, Tangen 9, 8200 Aarhus N, den 01.05.2023.
Formål ændret: Selskabets formål er kontraktforskning, laboratoriemæssig service og handel med knowhow og laboratorieydelser
Revision:
Fratrådte:
REVISIONSFIRMAET OLE VESTERGAARD, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 03.04.2023.
Tiltrådte:
CVR-NR. 20222670 BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, Kystvejen 29, 8000 Aarhus C, den 03.04.2023.
Stiftelsesdato: 29.08.2016.
Virkningsdato: 29.08.2016.
Seneste vedtægtsdato: 29.08.2016.
Kapital:
kr. 100.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 100.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
CVR-NR. 10096529 LADEGAARD HOLDING ApS, c/o Nicolai Hansen, Røvedvej 3, Spørring, 8380 Trige, den 29.08.2016, CVR-NR. 37964956 Lystlund Holding IVS, Løjenkærvej 11, Løjenkær, 8300 Odder, den 29.08.2016, CVR-NR. 37965014 Biotestx IVS, Skejbyvej 42, 8240 Risskov, den 29.08.2016.
Bestyrelse:
Nicolai Enevold Hansen (formand), den 29.08.2016, Carsten Leander Buus, den 29.08.2016, Agnete Lystlund Vestergaard, den 29.08.2016.
Direktion:
Carsten Leander Buus, den 29.08.2016.
Selskabet tegnes af den samlede bestyrelse..
Revision:
CVR-NR. 31501741 REVISIONSFIRMAET OLE VESTERGAARD, STATSAUTORISERET REVISIONSAKTIESELSKAB, Bakkevænget 16, 8990 Fårup, den 29.08.2016.
Første regnskabsår:
29.08.2016 - 31.12.2017.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at drive præklinisk kontraktforskning.
1 registered in CVR.
P-number 1021711663Røvedvej 1, 8380 Trige